Arika S Feils (A S Feils)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 12

Top Topics

Small Cell Lung Cancer

Acute Lymphoblastic Leukemia

Top Venues

Journal for immunotherapy of cancer

bioRxiv : the preprint server for biology

Cancer immunology, immunotherapy : CII

This page only lists publications with an associated author ORCID identifier.

Publications

Zachary T Rosenkrans, Amy K Erbe, Nathan B Clemons, Arika S Feils, Yadira Medina-Guevara, Justin J Jeffery, Todd E Barnhart, Johnathan W Engle, Paul M Sondel, Reinier Hernandez
Targeting both GD2 and B7-H3 using bispecific antibody improves tumor selectivity for GD2-positive tumors. bioRxiv : the preprint server for biology (2024)
Zachary T Rosenkrans, Amy K Erbe, Nathan B Clemons, Arika S Feils, Yadira Medina-Guevara, Justin J Jeffery, Todd E Barnhart, Johnathan W Engle, Paul M Sondel, Reinier Hernandez
Targeting both GD2 and B7-H3 using bispecific antibody improves tumor selectivity for GD2-positive tumors. bioRxiv : the preprint server for biology (2024)
Amy K Erbe, Mitch B Diccianni, Rajen Mody, Arlene Naranjo, Fan F Zhang, Jen Birstler, KyungMann Kim, Arika S Feils, Jung-Tung Hung, Wendy B London, Barry L Shulkin, Varsha Mathew, Marguerite T Parisi, Sabah Servaes, Shahab Asgharzadeh, John M Maris, Julie Park, Alice Lin-Tsing Yu, Paul M Sondel, Rochelle Bagatell
KIR/KIR-ligand genotypes and clinical outcomes following chemoimmunotherapy in patients with relapsed or refractory neuroblastoma: a report from the Children's Oncology Group. Journal for immunotherapy of cancer 11 (2) (2023)
Peter M Carlson, Ravi B Patel, Jen Birstler, Matthew Rodriquez, Claire Sun, Amy K Erbe, Amber M Bates, Ian Marsh, Joseph Grudzinski, Reinier Hernandez, Alexander A Pieper, Arika S Feils, Alexander L Rakhmilevich, Jamey P Weichert, Bryan P Bednarz, Paul M Sondel, Zachary S Morris
Radiation to all macroscopic sites of tumor permits greater systemic antitumor response to in situ vaccination. Journal for immunotherapy of cancer 11 (1) (2023)
Arika S Feils, Amy K Erbe, Jennifer Birstler, KyungMann Kim, U Hoch, S L Currie, T Nguyen, D Yu, Arlene O Siefker-Radtke, Nizar M Tannir, Sara M Tolaney, Adi Diab, Paul M Sondel
Associations between KIR/KIR-ligand genotypes and clinical outcome for patients with advanced solid tumors receiving BEMPEG plus nivolumab combination therapy in the PIVOT-02 trial. Cancer immunology, immunotherapy : CII (2023)
Peter M Carlson, Ravi B Patel, Jen Birstler, Matthew Rodriquez, Claire Sun, Amy K Erbe, Amber M Bates, Ian Marsh, Joseph Grudzinski, Reinier Hernandez, Alexander A Pieper, Arika S Feils, Alexander L Rakhmilevich, Jamey P Weichert, Bryan P Bednarz, Paul M Sondel, Zachary S Morris
Radiation to all macroscopic sites of tumor permits greater systemic antitumor response to in situ vaccination. Journal for immunotherapy of cancer 11 (1) (2023)
Amy K Erbe, Mitch B Diccianni, Rajen Mody, Arlene Naranjo, Fan F Zhang, Jen Birstler, KyungMann Kim, Arika S Feils, Jung-Tung Hung, Wendy B London, Barry L Shulkin, Varsha Mathew, Marguerite T Parisi, Sabah Servaes, Shahab Asgharzadeh, John M Maris, Julie Park, Alice Lin-Tsing Yu, Paul M Sondel, Rochelle Bagatell
KIR/KIR-ligand genotypes and clinical outcomes following chemoimmunotherapy in patients with relapsed or refractory neuroblastoma: a report from the Children's Oncology Group. Journal for immunotherapy of cancer 11 (2) (2023)
Peter M Carlson, Ravi B Patel, Jen Birstler, Matthew Rodriquez, Claire Sun, Amy K Erbe, Amber M Bates, Ian Marsh, Joseph Grudzinski, Reinier Hernandez, Alexander A Pieper, Arika S Feils, Alexander L Rakhmilevich, Jamey P Weichert, Bryan P Bednarz, Paul M Sondel, Zachary S Morris
Radiation to all macroscopic sites of tumor permits greater systemic antitumor response to in situ vaccination. Journal for immunotherapy of cancer 11 (1) (2023)
Amy K Erbe, Mitch B Diccianni, Rajen Mody, Arlene Naranjo, Fan F Zhang, Jen Birstler, KyungMann Kim, Arika S Feils, Jung-Tung Hung, Wendy B London, Barry L Shulkin, Varsha Mathew, Marguerite T Parisi, Sabah Servaes, Shahab Asgharzadeh, John M Maris, Julie Park, Alice Lin-Tsing Yu, Paul M Sondel, Rochelle Bagatell
KIR/KIR-ligand genotypes and clinical outcomes following chemoimmunotherapy in patients with relapsed or refractory neuroblastoma: a report from the Children's Oncology Group. Journal for immunotherapy of cancer 11 (2) (2023)
Peter M Carlson, Ravi B Patel, Jen Birstler, Matthew Rodriquez, Claire Sun, Amy K Erbe, Amber M Bates, Ian Marsh, Joseph Grudzinski, Reinier Hernandez, Alexander A Pieper, Arika S Feils, Alexander L Rakhmilevich, Jamey P Weichert, Bryan P Bednarz, Paul M Sondel, Zachary S Morris
Radiation to all macroscopic sites of tumor permits greater systemic antitumor response to in situ vaccination. Journal for immunotherapy of cancer 11 (1) (2023)
Peter M Carlson, Ravi B Patel, Jen Birstler, Matthew Rodriquez, Claire Sun, Amy K Erbe, Amber M Bates, Ian Marsh, Joseph Grudzinski, Reinier Hernandez, Alexander A Pieper, Arika S Feils, Alexander L Rakhmilevich, Jamey P Weichert, Bryan P Bednarz, Paul M Sondel, Zachary S Morris
Radiation to all macroscopic sites of tumor permits greater systemic antitumor response to in situ vaccination. Journal for immunotherapy of cancer 11 (1) (2023)
Peter M Carlson, Ravi B Patel, Jen Birstler, Matthew Rodriquez, Claire Sun, Amy K Erbe, Amber M Bates, Ian Marsh, Joseph Grudzinski, Reinier Hernandez, Alexander A Pieper, Arika S Feils, Alexander L Rakhmilevich, Jamey P Weichert, Bryan P Bednarz, Paul M Sondel, Zachary S Morris
Radiation to all macroscopic sites of tumor permits greater systemic antitumor response to in situ vaccination. Journal for immunotherapy of cancer 11 (1) (2023)